6533b86ffe1ef96bd12cd282
RESEARCH PRODUCT
Effects of beta-adrenoceptor drug stimulation on various models of gastric ulcer in rats.
José M. LlorisJuan V. EspluguesEsteban J. MorcilloEzequiel Marti-bonmatisubject
MaleTime FactorsStimulationPropranololPharmacologychemistry.chemical_compoundIsoprenalinemedicineGastric mucosaAnimalsHumansAlbuterolStomach UlcerPylorusPharmacologybusiness.industryIsoproterenolRats Inbred StrainsReserpineAdrenergic beta-AgonistsAtenololdigestive system diseasesRatsmedicine.anatomical_structurechemistryGastric MucosaAnesthesiaSalbutamolbusinessHistamineStress Psychologicalmedicine.drugResearch Articledescription
Abstract 1. Experiments were designed to evaluate the effect of the pharmacological activation of beta-adrenoceptors on various models of gastric ulcer in the rat. 2. Pretreatment with the beta-adrenoceptor stimulant drugs, isoprenaline or salbutamol, significantly inhibited stress-induced gastric ulcers. This anti-ulcer effect was abolished by propranolol but not by atenolol, suggesting that beta 2-adrenoceptors mediate this response. 3. In the pylorus-ligation model, salbutamol inhibited lesion formation and reduced the intragastric content of hydrogen ions, histamine and pepsin although the latter was only affected with the higher dose of salbutamol. 4. Salbutamol also prevented the ulcerogenic action on the gastric mucosa of an exogenously perfused artificial gastric juice, showing that the anti-ulcer effect is not necessarily dependent on acid inhibition. 5. Salbutamol also reduced the formation of acute ulcers induced by various iatrogenic means (histamine, polymyxin B, reserpine and indomethacin). 6. Long-term treatment with salbutamol accelerated the healing of experimental chronic gastric ulcer. 7. In anaesthetized rats, salbutamol produced a dose-related increase in mucosal blood flow which may contribute to its mode of action. 8. It is concluded that beta-adrenoceptor agonists exert preventive and curative effects on gastric damage induced in the rat. This effect seems specific and mediated through beta-adrenoceptor activation.
year | journal | country | edition | language |
---|---|---|---|---|
1982-08-01 | British journal of pharmacology |